In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Stay Of Sunscreen Final Monograph Requested By CTFA

This article was originally published in The Tan Sheet

Executive Summary

The Cosmetic, Toiletry and Fragrance Association is asking FDA to "stay and/or refrain" from publishing the OTC sunscreen final monograph and delay the effective date of the final OTC drug labeling rule as it relates to sunscreens. The FDA Modernization Act requires a sunscreen reg to be final by May 19.

You may also be interested in...



Sunscreen Monograph Effective Date Extended To Address UVA Standards

The Dec. 31, 2002 implementation date of the OTC sunscreen final monograph has been postponed until further notice for the majority of sunscreens, FDA announces

Sunscreen Monograph Effective Date Extended To Address UVA Standards

The Dec. 31, 2002 implementation date of the OTC sunscreen final monograph has been postponed until further notice for the majority of sunscreens, FDA announces

FDA Extends Sunscreen Monograph Implementation Date To December 2002

The effective date of the OTC sunscreen final monograph will be extended by FDA for a year-and-a-half until Dec. 31, 2002, following a request from the Cosmetic, Toiletry & Fragrance Association, the agency says in an Oct. 1 letter to the trade group.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089678

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel